Healthcare Archives - Page 17 of 19 - Boston Life Sciences Times

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

November 6, 2026

Two Cambridge MedTech Companies Named Finalists in MedTech Innovator’s 2026 Grand Prize Competition

November 5, 2026

Insulet Third-Quarter Profit Jumps 61% to $141.1 Million as Revenue Climbs to $842 Million

November 4, 2026

THIS WEEK'S STORIES

Enveric Biosciences Reports Distinct Brain Activity Results for Experimental Neurological Drug EB-003

November 4, 2026

Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials

November 6, 2026

More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12

November 2, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Healthcare

More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12

Baystate Health Integrates Mercy Hospital and 45 Medical Practices, Launches New Electronic Health Record System

NeoGenomics Reports 11% Revenue Growth to $209 Million, Narrows Third-Quarter Loss

Cambridge-Based Bild Health Launches App to Help GLP-1 Users Preserve Muscle During Weight Loss

Daily Peanut Consumption May Improve Brain Insulin Response in Older Adults, Study Finds

Most Read

Agenus Reports 51% of Colorectal Cancer Patients Survived at Least 18 Months Following Experimental Immunotherapy

Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials

Tandem Diabetes Care Appoints Jeannette Bankes as CEO, Succeeding John Sheridan

Sarepta Therapeutics Narrows Third-Quarter Loss to $28.5 Million, Advances Rare Disease Drug Programs

EDITOR PICKS

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

Two Cambridge MedTech Companies Named Finalists in MedTech Innovator’s 2026 Grand Prize Competition

Insulet Third-Quarter Profit Jumps 61% to $141.1 Million as Revenue Climbs to $842 Million

THIS WEEK'S STORIES

Enveric Biosciences Reports Distinct Brain Activity Results for Experimental Neurological Drug EB-003

Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials

More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12

POPULAR CATEGORY

ABOUT US

FOLLOW US